Review





Similar Products

cd151 antibody  (R&D Systems)
90
R&D Systems cd151 antibody
Figure 3. O-GlcNAc protein modification was increased in the subjects’ podocytes. (A) A schematic diagram showing the podocyte purification procedure. (B) Representative immunofluorescence images of the WT1 staining and the quantification of the positive rates in the pulled-down and flow-through cells (we randomly selected five fields of view per mouse for analysis, n = 3 mice per group). (C) Flow cytometry analysis of the <t>CD151</t> positive cells and the quantification of the positive rates in the different groups (n = 3). (D) Representative immunoblotting of O-GlcNAcylation in the pulled-down podocytes and quantification of the expression levels in the different groups (n = 3 blots in total). (E) Representative dual-immunofluorescence staining image and quantification of the colocalization areas in the different groups, squares highlight the representative colocalization areas (we randomly selected five fields of view per mouse for analysis, n = 3 mice per group). Z, zoom. * p < 0.05 and ** p < 0.01 using one-way ANOVA, followed by Tukey tests (D,E) or Student’s t-tests (B,C). The scale bars = 20 µm.
Cd151 Antibody, supplied by R&D Systems, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/cd151 antibody/product/R&D Systems
Average 90 stars, based on 1 article reviews
cd151 antibody - by Bioz Stars, 2026-02
90/100 stars
  Buy from Supplier
cd151 antibody  (Exosome Diagnostics)
90
Exosome Diagnostics cd151 antibody
Figure 6. Flow cytometry diagram to calculate the number of exosomes by <t>CD151-labeled</t> antibody.
Cd151 Antibody, supplied by Exosome Diagnostics, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/cd151 antibody/product/Exosome Diagnostics
Average 90 stars, based on 1 article reviews
cd151 antibody - by Bioz Stars, 2026-02
90/100 stars
  Buy from Supplier

Image Search Results


Figure 3. O-GlcNAc protein modification was increased in the subjects’ podocytes. (A) A schematic diagram showing the podocyte purification procedure. (B) Representative immunofluorescence images of the WT1 staining and the quantification of the positive rates in the pulled-down and flow-through cells (we randomly selected five fields of view per mouse for analysis, n = 3 mice per group). (C) Flow cytometry analysis of the CD151 positive cells and the quantification of the positive rates in the different groups (n = 3). (D) Representative immunoblotting of O-GlcNAcylation in the pulled-down podocytes and quantification of the expression levels in the different groups (n = 3 blots in total). (E) Representative dual-immunofluorescence staining image and quantification of the colocalization areas in the different groups, squares highlight the representative colocalization areas (we randomly selected five fields of view per mouse for analysis, n = 3 mice per group). Z, zoom. * p < 0.05 and ** p < 0.01 using one-way ANOVA, followed by Tukey tests (D,E) or Student’s t-tests (B,C). The scale bars = 20 µm.

Journal: International journal of molecular sciences

Article Title: ER Stress-Perturbed Intracellular Protein O-GlcNAcylation Aggravates Podocyte Injury in Diabetes Nephropathy.

doi: 10.3390/ijms242417603

Figure Lengend Snippet: Figure 3. O-GlcNAc protein modification was increased in the subjects’ podocytes. (A) A schematic diagram showing the podocyte purification procedure. (B) Representative immunofluorescence images of the WT1 staining and the quantification of the positive rates in the pulled-down and flow-through cells (we randomly selected five fields of view per mouse for analysis, n = 3 mice per group). (C) Flow cytometry analysis of the CD151 positive cells and the quantification of the positive rates in the different groups (n = 3). (D) Representative immunoblotting of O-GlcNAcylation in the pulled-down podocytes and quantification of the expression levels in the different groups (n = 3 blots in total). (E) Representative dual-immunofluorescence staining image and quantification of the colocalization areas in the different groups, squares highlight the representative colocalization areas (we randomly selected five fields of view per mouse for analysis, n = 3 mice per group). Z, zoom. * p < 0.05 and ** p < 0.01 using one-way ANOVA, followed by Tukey tests (D,E) or Student’s t-tests (B,C). The scale bars = 20 µm.

Article Snippet: For the podocyte pull-down efficiency confirmation, the cells were then incubated with the CD151 antibody (Cat#FAB4609A, R&D System, Minneapolis, MN, USA) for half an hour at 4 ◦C and protected from light.

Techniques: Modification, Purification, Immunofluorescence, Staining, Flow Cytometry, Western Blot, Expressing

Figure 6. Flow cytometry diagram to calculate the number of exosomes by CD151-labeled antibody.

Journal: International journal of molecular sciences

Article Title: Lung Cancer Cell-Derived Exosome Detection Using Electrochemical Approach towards Early Cancer Screening.

doi: 10.3390/ijms242417225

Figure Lengend Snippet: Figure 6. Flow cytometry diagram to calculate the number of exosomes by CD151-labeled antibody.

Article Snippet: Exosome concentration tests using th CD151 antibody in an electrochemical system. (A) The CV diagram shows the changes in the current with each layering step.

Techniques: Flow Cytometry, Labeling

Figure 7. Exosome concentration tests using the CD151 antibody in an electrochemical system. (A) The CV diagram shows the changes in the current with each layering step. In the last step, the binding of exosomes to the antibody caused a decrease in the current. (B) EIS diagram showing changes in surface resistance with each layering step. In the last step, the binding of exosomes to antibodies increased the resistance.

Journal: International journal of molecular sciences

Article Title: Lung Cancer Cell-Derived Exosome Detection Using Electrochemical Approach towards Early Cancer Screening.

doi: 10.3390/ijms242417225

Figure Lengend Snippet: Figure 7. Exosome concentration tests using the CD151 antibody in an electrochemical system. (A) The CV diagram shows the changes in the current with each layering step. In the last step, the binding of exosomes to the antibody caused a decrease in the current. (B) EIS diagram showing changes in surface resistance with each layering step. In the last step, the binding of exosomes to antibodies increased the resistance.

Article Snippet: Exosome concentration tests using th CD151 antibody in an electrochemical system. (A) The CV diagram shows the changes in the current with each layering step.

Techniques: Concentration Assay, Binding Assay